{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:14:57Z","timestamp":1791976497076,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,9,1]],"date-time":"1996-09-01T00:00:00Z","timestamp":841536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1996,9]]},"DOI":"10.1007\/bf02229648","type":"journal-article","created":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T22:53:19Z","timestamp":1129848799000},"page":"491-494","source":"Crossref","is-referenced-by-count":23,"title":["The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): A masked and controlled study"],"prefix":"10.1007","volume":"15","author":[{"given":"Akgun","family":"Ince","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Hamuryudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02229648_CR1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/anr.1780320603","volume":"32","author":"G.S. Alarcon","year":"1989","unstructured":"Alarcon, G.S., Tracy, I.C., Blackburn, W.D. Methotrexate in limiting long-term treatment. Arthritis Rheum 1989, 32, 671\u2013677.","journal-title":"Arthritis Rheum"},{"key":"BF02229648_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00002281-199206000-00004","volume":"4","author":"P. Brooks","year":"1992","unstructured":"Brooks, P. Current issues of methotrexate and cyclosporine. Current Opinion in Rheumatol 1992, 4, 309\u2013313.","journal-title":"Current Opinion in Rheumatol"},{"key":"BF02229648_CR3","first-page":"639","volume":"20","author":"R. Buchbinder","year":"1993","unstructured":"Buchbinder, R., Hall, S., Sambrook, P.N., et al. Methotrexate therapy in rheumatoid arthritis: A life table review of 587 patients treated in community practice. J Rheumatol 1993, 20, 639\u2013644.","journal-title":"J Rheumatol"},{"key":"BF02229648_CR4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.1780351003","volume":"35","author":"D.T. Felson","year":"1992","unstructured":"Felson, D.T., Anderson, J.J., Meenan, R.F. Use of short term efficacy-toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. Arthritis Rheum, 1992, 35, 1117\u20131125.","journal-title":"Arthritis Rheum"},{"key":"BF02229648_CR5","volume-title":"Behcet Sendromu aftlarinda lokal alfainterferon tedavisi: Plasebo kontrollu cift kor bir calisma","author":"V. Hamuryudan","year":"1991","unstructured":"Hamuryudan, V. Behcet Sendromu aftlarinda lokal alfainterferon tedavisi: Plasebo kontrollu cift kor bir calisma. MD Thesis, Cerrahpasa Medical Faculty, Istanbul, 1991."},{"key":"BF02229648_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.1780350203","volume":"35","author":"J.M. Kremer","year":"1992","unstructured":"Kremer, J.M., Phelps, J.T. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 1992, 35, 138\u2013145.","journal-title":"Arthritis Rheum"},{"key":"BF02229648_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/31.11.767","volume":"31","author":"D.M.G. Main","year":"1992","unstructured":"Main, D.M.G., Chamberlain, M.A. Clinical differentiation of oral ulceration in Beh\u00e7et's disease. Br J Rheumatol 1992, 31, 767\u2013770.","journal-title":"Br J Rheumatol"},{"key":"BF02229648_CR8","first-page":"1850","volume":"20","author":"R.J.R. McKendry","year":"1993","unstructured":"McKendry, R.J.R., Dale, P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 1993, 20, 1850\u20131856.","journal-title":"J Rheumatol"},{"key":"BF02229648_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/art.1780370525","volume":"37","author":"C. Montecucco","year":"1993","unstructured":"Montecucco, C., Caporali, R., Rossi, S., Porta, C. Allopurinol mouthwashes in methotrexate-induced stomatitis. Arthritis Rheum 1993, 37, 777\u2013779.","journal-title":"Arthritis Rheum"},{"key":"BF02229648_CR10","first-page":"704","volume":"19","author":"E.F. Morand","year":"1992","unstructured":"Morand, E.F., McCloud, P.L., Littlejohn, G.O. Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol 1992, 19, 704\u2013708.","journal-title":"J Rheumatol"},{"key":"BF02229648_CR11","first-page":"123","volume":"16","author":"J.D. O'Duffy","year":"1990","unstructured":"O'Duffy, J.D. Vasculitis in Beh\u00e7et's disease. Rheumatic Dis Clin of N Am 1990, 16, 123\u2013131.","journal-title":"Rheumatic Dis Clin of N Am"},{"key":"BF02229648_CR12","first-page":"390","volume-title":"Internal Medicine for Dentistry","author":"S.W. Redding","year":"1990","unstructured":"Redding, S.W. Dental correlation: chemotherapy. In: Internal Medicine for Dentistry. Eds.: L.F. Rose and D. Kaye. The C.V. Mosby Co., St. Louis, 2nd ed., Section VI; 1990, pp. 390\u2013393.","edition":"2nd ed."},{"key":"BF02229648_CR13","first-page":"621","volume-title":"Arthritis and Allied Conditions","author":"T.W. Rooney","year":"1993","unstructured":"Rooney, T.W. Methotrexate. In: Arthritis and Allied Conditions. 12th ed. Eds.: D.J. McCarty and W.J. Koopman. Lea & Febiger Co., Philadelphia, 1993, Chapter 34, pp. 621\u2013637.","edition":"12th ed."},{"key":"BF02229648_CR14","first-page":"796","volume":"36","author":"J.B. Shiroky","year":"1993","unstructured":"Shiroky, J.B., Neville, C., Esdaile, J.M. et al. Low-dose methotrexate with leucovorin in the management of rheumatoid arthritis. Arthritis Rheum 1993, 36, 796\u2013803.","journal-title":"Arthritis Rheum"},{"key":"BF02229648_CR15","first-page":"188","volume":"18","author":"G. Singh","year":"1991","unstructured":"Singh, G., Fries, J.F., Williams, C.A. et al. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol 1991, 18, 188\u2013194.","journal-title":"J Rheumatol"},{"key":"BF02229648_CR16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-107-2-358","volume":"107","author":"P. Tugwell","year":"1987","unstructured":"Tugwell, P., Bennett, K., Gent, M. Methotrexate in rheumatoid arthritis. Ann Intern Med 1987, 107, 358\u2013366.","journal-title":"Ann Intern Med"},{"key":"BF02229648_CR17","first-page":"334","volume":"18","author":"M.E. Weinblatt","year":"1991","unstructured":"Weinblatt, M.E., Kaplan, H., Germain, B.F. et al. Methotrexate in rheumatoid arthritis: Effects on disease activity in a multicenter prospective study. J Rheumatol 1991, 18, 334\u2013338.","journal-title":"J Rheumatol"},{"key":"BF02229648_CR18","first-page":"950","volume":"20","author":"M.E. Weinblatt","year":"1993","unstructured":"Weinblatt, M.E., Maier, A.L., Coblyn, J. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: An eight-week randomized placebo controlled trial. J Rheumatol 1993, 20, 950\u2013952.","journal-title":"J Rheumatol"},{"key":"BF02229648_CR19","first-page":"994","volume":"17","author":"F. Wolfe","year":"1990","unstructured":"Wolfe, F., Hawley, D.J., Cathey, M.A. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990, 17, 994\u20131002.","journal-title":"J Rheumatol"},{"key":"BF02229648_CR20","first-page":"973","volume":"18","author":"F. Wolfe","year":"1991","unstructured":"Wolfe, F., Cathey, M.A. The effect of age on methotrexate efficacy and toxicity. J Rheumatol 1991, 18, 973\u2013977.","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02229648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02229648\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02229648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T22:50:53Z","timestamp":1557874253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02229648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["BF02229648"],"URL":"https:\/\/doi.org\/10.1007\/bf02229648","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}